Omnicell (OMCL) Capital Expenditures (2010 - 2026)

Omnicell (OMCL) has 17 years of Capital Expenditures data on file, last reported at -$1.3 million in Q1 2026.

• On a quarterly basis, Capital Expenditures rose 21.39% year-over-year to -$1.3 million in Q1 2026; TTM through Mar 2026 was -$3.7 million, a 110.88% decrease from a year earlier, with the FY2025 full-year figure at -$4.1 million, down 111.21% from the prior year.
• Capital Expenditures for Q1 2026 stood at -$1.3 million, down from $1.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for OMCL reached as high as $32.4 million in Q3 2022 and fell as low as -$33.0 million in Q4 2022.
• Historically, Capital Expenditures has averaged $1.9 million across 5 years, with a median of $483000.0 in 2024.
• Across the five-year window, Capital Expenditures tumbled 17271.35% in 2022 and soared 1546.38% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at -$33.0 million in 2022, then increased by 4.37% to -$31.5 million in 2023, then soared by 128.82% to $9.1 million in 2024, then tumbled by 79.84% to $1.8 million in 2025, then plunged by 170.8% to -$1.3 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$1.3 million in Q1 2026, $1.8 million in Q4 2025, and -$28.9 million in Q3 2025.